id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
PHMSA-RSPA-1998-3311-0007,PHMSA,PHMSA-RSPA-1998-3311,U.S. DOT/RSPA - Exemption/Grant (Second Revision),Other,Exemption/Waiver,2000-10-31T05:00:00Z,2000,10,2000-10-31T05:00:00Z,2000-12-15T04:59:59Z,2008-01-08T20:21:37Z,,0,0,090000648031f876
PHMSA-RSPA-1998-3311-0006,PHMSA,PHMSA-RSPA-1998-3311,Pfizer Inc. - Renewal/Exemption of DOT-E-12024,Other,Application,2000-10-02T04:00:00Z,2000,10,2000-10-02T04:00:00Z,2000-12-15T04:59:59Z,2008-01-08T20:17:18Z,,0,0,090000648031f875